Brief: Proteomics International Laboratories Says Terminated Exclusive Licence Agreement With Sonic Healthcare USA
Sept 11 (Reuters) - Proteomics International
Laboratories Ltd PIQ.AX :
* TERMINATED ITS EXCLUSIVE LICENCE AGREEMENT WITH SONIC
HEALTHCARE
USA
* LICENCE AGREEMENT FOR USE AND COMMERCIALISATION OF
PROMARKERD
TEST IN USA
Further company coverage: PIQ.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Proteomics International Laboratories
See all newsBrief: Proteomics International Laboratories Launches Share Purchase Plan To Raise Up To A$5 MLN
Australia's Proteomics slips to four-month low on discounted share sale plan
Brief: Proteomics International Laboratories Posts FY Loss Attributable A$8.6 Million
Brief: Proteomics International Laboratories Signs Agreement With Healius For Promarker Portfolio
Australia's Proteomics International soars on distribution deal with Healius